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Background
Intracellular iron and oxygen levels regulate HIV-1 replica-
tion by affecting several steps in the HIV-1 life cycle
including transcription [1]. Low oxygen levels and reduced
cellular iron are inhibitory as CDK9/cyclin T1 and CDK2/
cyclin E activities are reduced and HIV-1 transcription is
inhibited. The alpha subunit of hypoxia-induced factor 1
(HIF1a) is stabilized under hypoxia and in the conditions
of low cellular iron. Iron depletion by iron chelators or
through the expression of ferroportin, an iron export pro-
tein, inhibits CDK2 and CDK9 activities and blocks HIV-1
transcription [1]. As neither CDK2 nor CDK9 requires iron
for their enzymatic activity, an apparent upstream regula-
tion is involved. Also, induction of heme oxygenase-1
(HO-1) by hemin was shown to inhibit HIV-1 [1] although
the mechanism of the inhibition was not clarified. Here we
analyzed the effect of iron chelators on HIV-1 transcription
and replication and also analyzed the effect of heme, a con-
dition present in sickle cell disease that may protect against
HIV-1 infection [2].
Results
Novel iron chelators, PpY-eT and PpY-aT, efficiently
inhibited HIV-1 and induced the expression of IkBa, an
inhibitor of NF-kB, that was not previously reported. The
chelators also induce the expression of HIF1a, increased
the expression of p21, inhibited enzymatic activity of
CDK2 and shifted CDK9 from the large to the small com-
plex. HIF1a knockdown in promonocytic THP1 cells led
to increased HIV-1 replication suggesting that HIF1a may
restrict HIV-1. Treatment with hemin induced both HO-1
and ferroportin expression and inhibited HIV-1. Hemin
treatment also induced expression of IkBa, HIF1a and
p21 thus mimicking the effect of iron chelators. Peripheral
blood mononuclear cells obtained from patients with
sickle cell disease showed increased expression of HO-1,
ferroportin, IkBa and p21 and reduced ex-vivo HIV-1
replication.
Conclusions
HIV-1 transcription and replication is inhibited in low
intracellular iron conditions which leads to the induction
of IkBa, HIF1a and p21, resulting in inhibition of CDK2
and CDK9. The hemolytic conditions of sickle cell disease
may stimulate ferroportin expression and intracellular iron
reduction leading to the inhibition of HIV-1.
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